C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
To address the preventive & primary healthcare delivery gaps in India
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
